January 18, 2021
Business News

Genprex to Present at NobleCon17 on January 19

AUSTIN, Texas–()–Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the Company will present at the NobleCon17, Noble Capital Markets’ Annual Investor Conference, taking place virtually January 19-20. Genprex’s President and Chief Executive Officer, Rodney Varner, will virtually deliver a company overview, including recent progress made on its upcoming clinical trials, to participating investors.

Event: NobleCon17

Presentation Date: Tuesday, January 19

Presentation Time: 3:45 p.m. EST – Track 1

Registration Link: https://bit.ly/3oAVY1c


Click here to view the original article.

Related Posts

You might also like ...

Topcon annonce les symposiums et l’expo virtuels eyeRISE 2021
BET Joins Forces with [tbh] In the Fight to Combat Hate for National Religious Freedom Day and Martin Luther King Day
Samenvatting: EG Group kiest PDI om contactloze betalingen naar zijn Noord-Amerikaanse sites te brengen